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Background: Octogenarians (people >80 years of age) have been excluded from studies looking at long term outcomes of Percutaneous Coronary 
Intervention (PCI). The aim of this study was to evaluate long-term outcomes of PCI with either Bare Metal Stent (BMS) or Drug Eluting Stent (DES) 
placement in Octogenarians.
Methods: Retrospective data was collected for 334 consecutive patients who underwent PCI during January 2003 to December 2009 at Carle 
Foundation Hospital.
Results: The patients were stratified based on the type of stent placed: BMS (n=243) or DES (n=91). Both groups had identical baseline risk 
characteristics. A total of 68 patients developed in-stent restenosis: 21.8% with BMS and 16.5% with DES (p=0.28). There was no significant 
relationship between type of stent placed and either recurrent MI, Target Vessel Revascularization (TVR) or death due to all causes. The duration for 
in-stent restenosis was 13.7±10.9 months for BMS and 20.7±17.5 months for DES (p=0.05). There was no significant difference in survival between 
each group.
Conclusion: This study revealed that long-term outcomes of DES are comparable to BMS in Octogenarians. There was a trend towards decrease in 
the rate for development of in-stent restenosis with DES but this was not statistically significant. In octogenarians with high risk characteristics, DES 
placement can reduce the frequency of repeat revascularization; however the risk of prolonged dual anti-platelet therapy needs further evaluation. 
